ConductScience.org, home

Paper29427770

Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis.

Cargnin S and 4 others. Pharmacol Res, 2018. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis. Papers, record 29427770. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29427770

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis.
PubMed
Journal
Pharmacol Res
PubMed
Year
2018
PubMed
Publication types
Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
1.1
iCite
Revised in PubMed
2022-12-07
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cargnin SSarah
2Ravegnini GGloria
3Soverini SSimona
4Angelini SSabrina
5Terrazzino SSalvatore

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Cytochrome P-450 CYP3AMajor topic
Imatinib MesylateMajor topic
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMajor topic
Organic Cation Transporter 1Major topic
Polymorphism, Single NucleotideMajor topic
Asian People
Genotype
Humans

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
41455147Interindividual variability in imatinib metabolism in human liver microsomes and primary human hepatocytes: Impact of CYP2C8 and CYP3A phenotypes.Drug Metab Dispos2025https://conductscience.org/library/papers/41455147PubMed
41295218The Three Musketeers in Cancer Therapy: Pharmacokinetics, Pharmacodynamics and Personalised Approach.J Pers Med2025https://conductscience.org/library/papers/41295218PubMed
40868933Role of OCT1 and MAP3K5 Genetic Polymorphisms in Hydroxyurea Pharmacokinetics.Life (Basel)2025https://conductscience.org/library/papers/40868933PubMed
40731166Understanding and overcoming multidrug resistance in cancer.Nat Rev Clin Oncol2025https://conductscience.org/library/papers/40731166PubMed
39523378CYP3A4*1B and CYP3A5*3 SNPs significantly impact the response of Egyptian candidates to high-intensity statin therapy to atorvastatin.Eur J Med Res2024https://conductscience.org/library/papers/39523378PubMed
39143954Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy.Cancer Drug Resist2024https://conductscience.org/library/papers/39143954PubMed
38646295Current Progress on the Influence Human Genetics Has on the Efficacy of Tyrosine Kinase Inhibitors Used to Treat Chronic Myeloid Leukemia.Cureus2024https://conductscience.org/library/papers/38646295PubMed
36882601Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia.Handb Exp Pharmacol2023https://conductscience.org/library/papers/36882601PubMed
36834713Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis.Int J Mol Sci2023https://conductscience.org/library/papers/36834713PubMed
36467365Polymorphisms in drug metabolism genes predict the risk of refractory myasthenia gravis.Ann Transl Med2022https://conductscience.org/library/papers/36467365PubMed
36294538Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients.J Clin Med2022https://conductscience.org/library/papers/36294538PubMed
36077209Genetic Variants of ABC and SLC Transporter Genes and Chronic Myeloid Leukaemia: Impact on Susceptibility and Prognosis.Int J Mol Sci2022https://conductscience.org/library/papers/36077209PubMed
35720392
Single Nucleotide Polymorphisms (SNP) and SNP-SNP Interactions of the Surfactant Protein Genes Are Associated With Idiopathic Pulmonary Fibrosis in a Mexican Study Group; Comparison With Hypersensitivity Pneumonitis.
Front Immunol2022https://conductscience.org/library/papers/35720392PubMed
35582588Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma.Cancer Drug Resist2019https://conductscience.org/library/papers/35582588PubMed
35546460Evaluation of genetic polymorphism of CYP3A5 in normal healthy participants from western India - A cross-sectional study.Indian J Pharmacol2022https://conductscience.org/library/papers/35546460PubMed
35456416The Role of SLC22A1 and Genomic Ancestry on Toxicity during Treatment in Children with Acute Lymphoblastic Leukemia of the Amazon Region.Genes (Basel)2022https://conductscience.org/library/papers/35456416PubMed
34262462Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia.Front Pharmacol2021https://conductscience.org/library/papers/34262462PubMed
33381028Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia.Front Pharmacol2020https://conductscience.org/library/papers/33381028PubMed
31679053The genetic landscape of the human solute carrier (SLC) transporter superfamily.Hum Genet2019https://conductscience.org/library/papers/31679053PubMed
31404235Effects of Comedication and Genetic Factors on the Population Pharmacokinetics of Lamotrigine: A Prospective Analysis in Chinese Patients With Epilepsy.Front Pharmacol2019https://conductscience.org/library/papers/31404235PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP3A51577PubTator's text mininghttps://conductscience.org/library/genes/1577NCBI Gene
SLC22A16580PubTator's text mininghttps://conductscience.org/library/genes/6580NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29427770

GET https://conductscience.org/api/papers/v1/29427770/authors